About the Translational Workshop on Hematologic Malignancies

The goal of Translational Workshop on Hematologic Malignancies is to foster collaboration between experts so that currently available tumor microenvironment targeted therapies are used optimally, and more importantly, to fuel the development of novel microenvironment targeted therapies.

The workshop was first held nine years ago in Dublin, Ireland bringing key global leaders in academia and industry together to brainstorm how to accelerate the development of microenvironment-focused therapy in hematologic malignancies. The meeting will focus on emerging trends in the analysis and interpretation of the interface of medicine and the tumor-immune microenvironment in hematologic malignancies. This interactive educational program will bring together key global experts from academia and industry to discuss data and to share current understandings of the complex interaction between hematologic malignancies and the microenvironment.


Dunleavy Kieron

Kieron Dunleavy, MD

Learn More

img 02@2x 786x600 1

John Gribben, DSc, FRCP, FRCPath

Barts Cancer Institute
Learn More

img 03@2x 786x600 1

Sagar Lonial, MD, FACP

Winship Cancer Institute of Emory University
Learn More

susan obrien

Susan O’Brien, MD

University of
California Irvine
Learn More

Photos from Previous Workshops